RALEIGH, NC–(BUSINESS WIRE)–Phreesia is pleased to announce that it is now part of MEDITECH Greenfield, a testing ground for applications that can integrate with MEDITECH Expanse. This collaboration with MEDITECH will allow Phreesia to better enable patients to play a more active role in their care.
Through the Greenfield program, Phreesia seeks to:
Enable API-based integration between MEDITECH and Phreesia, bringing even more value to our joint customers
Proactively inform patients of gaps in their preventive care and encourage them to take action to close those gaps
Reduce barriers to care for all patients
Establish an industry standard for interoperability
“As the healthcare industry continues to move towards greater interoperability, programs like MEDITECH Greenfield are all the more important,” said Phreesia CEO Chaim Indig. “We are delighted to join Greenfield, which will help us continue to develop innovative products and solutions for MEDITECH customers that improve patient experience and outcomes, as well as better access to care. »
This press release contains express or implied statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Forward-looking statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and may contain projections of our future operating results or financial information or state other forward-looking information. In some cases, you can identify forward-looking statements by the following words: “may”, “will”, “could”, “would”, “should”, “expect”, “intend”, “plan”, “anticipate”. “, “believe”, “estimate”, “predict”, “project”, “potential”, “continue”, “in progress” or the negative form of these terms or other comparable terms, although all forward-looking statements do not contain these terms. words. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operating or financial performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, performance or achievements. differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. In addition, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors beyond our control, including, without limitation, our ability to achieve the anticipated benefits from our collaboration with MEDITECH. when scheduled or not at all; changes in laws and regulations applicable to our business model; changes in market conditions and receptivity to our products and services; our ability to effectively manage our anticipated growth; the impact of the COVID-19 pandemic on our business; and our ability to attract, retain and cross-sell with healthcare provider customers. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including, without limitation, those described in greater detail in our filings with the Securities and Exchange Commission (“SEC”), including included in item 1A. Risk Factors from our Annual Report on Form 10-K for the fiscal year ended January 31, 2021, as updated by our quarterly reports subsequently filed on Form 10-Q, and our other filings with the SEC. The forward-looking statements contained in this press release speak only as of the date the statements are made. We undertake no obligation to update, and expressly disclaim the obligation to update, any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unforeseen events, except as required by law.
Phreesia offers healthcare organizations a suite of robust applications to manage the patient admission process. Our innovative SaaS platform engages patients in their healthcare and delivers a modern, convenient experience, while enabling our customers to improve clinical care and increase efficiency.
Copyright © acrofan/Business Wire All Rights Reserved